Exploring prevalence and drivers of perimenopause uncertainty among US Women: a mixed-methods study.

Yihan Xu¹, Deirbhle Fergus^1,2,3, Yella Hewings-Martin¹, Mary Hedges⁴, Carley Prentice¹, Adam Cunningham¹, Liudmila Zhaunova¹, Chrisandra Shufelt^4,5, Stephanie Faubion^4,5

¹Flo Health Inc., London, UK.

²Institute of Epidemiology & Health, University College London, London, UK.

³School of Population Health, Royal College of Surgeons in Ireland, Dublin, Ireland.

⁴Department of Medicine, Mayo Clinic, Jacksonville, FL.

⁵Center for Women's Health, Mayo Clinic, Rochester, MN.

PubMed DOI

Abstract

OBJECTIVE: Perimenopause is an under-recognized life stage that is often accompanied by complex and fluctuating symptoms. We aimed to quantify the prevalence of perimenopause uncertainty and explore the underlying drivers. METHODS: We conducted a mixed-methods study using a cross-sectional survey of US women aged 35 years and above (N=7,640). We estimated the prevalence of perimenopause uncertain…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.